Faeth Therapeutics grants new-hire stock options for 25,500 shares at $28.19 each
FTH•New-hire option grant under 2026 Inducement Plan
Faeth Therapeutics granted new-hire stock options covering 25,500 shares under its 2026 Inducement Plan, effective July 20, 2026.
- The options carry a $28.19 exercise price, matching the stock’s closing price on the grant date.
- Vesting starts with 25% after one year, then continues in 36 monthly installments, subject to continued service.
